2. Was musculoskeletal pain assessed for? Intermittent chest pain without other cardio-like signs and symptoms, especially in the elderly, by my experience, can be due to bad backs, consto-chondritis, or even referred pain.
This is a valid point, but it's also worth remembering that somewhere around 5-10% of patients experiencing an acute MI may have point tenderness that's reproducible upon palpation. So point tenderness on physical examination alone can't be considered a rule-out.
Swap CJ, Nagurney JT. Value and limitations of chest pain history
in the evaluation of patients with suspected acute coronary
syndromes. J Am Med Assoc 2005; 294:2623–9.
The usual and cautious admin of oral nitroglycerine is allowed to be "assisted" by Am Red Cross basic first-aid-ers, certainly without an IV lines.
But it must be prudent, appropriate and cautious as with any drug; cowboy "rules of thumb" should never dictate medicating anyone, especially the fragile elderly.
But of course, this is comparing apples and oranges. A paramedic has a greater scope of practice, more diagnostic tools at their disposal, and a duty to act. If the various first aid organisations advise NTG assist for a lay person acting as a Good Samaritan, that shouldn't be inferred to be the standard of practice for a "professional", such as a paramedic.
I agree with many people who've said that the risk of a particular patient being preload-sensitive is very low. And that's correct. But why expose the patient to this risk when there's a tool that will allow us to identify some high risk patients (12/15-lead ECG), and an intervention (IV therapy) that will allow us to rapidly treat potential complications of a medication (NTG) that is known to be dangerous to some patients?
I just don't see a benefit that's outweighing that risk. What are we hoping to achieve by giving NTG five minutes earlier? Hey, maybe I'm a dangerous idiot, but it just seems wise to get that IV and 12-lead before giving the NTG. These (along with ASA), are interventions that are far more important. They cut down the time to reperfusion therapy, they allow us to identify patients that may benefit from thrombolytics, and enable us to administer them. Why prioritise NTG over a 12-lead or IV, especially when having these is going to (1) allow us to avoid giving NTG to high-risk patients and (2) make giving NTG to the remaining population safer?